🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was: \- to assess the bioequivalence of a single dos...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-09
Trial ID
NCT02237508
This is a randomized, multi-center, active-controlled, repeated measures de...
Status
Completed
Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Start Date
2016-04
Trial ID
NCT02757209
A Randomized, Double-Blind, Parallel Group, 28-Week Chronic Dosing, Multi-C...
Status
Completed
Location
Research Site
Start Date
2016-08-09
Trial ID
NCT03262012
Treatments Being Tested
This study is conducted to assess whether training participants on proper u...
Status
Completed
Location
Teva Investigational Site 34092
Start Date
2014-05-28
Trial ID
NCT02062463
This study has a randomized multiple-dose, placebo-controlled, parallel gro...
Status
Completed
Location
Site 100
Start Date
2017-01-13
Trial ID
NCT02495168
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2009-09
Trial ID
NCT00964535
Computational Fluid Dynamics (CFD) is a new functional imaging method. Sinc...
Status
Completed
Location
University Hospital Antwerp
Start Date
2010-06
Trial ID
NCT01329276
Treatments Being Tested
The primary objective is to compare the efficacy of Symbicort Single inhale...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00290264
Treatments Being Tested
Primary objective: The primary objective of this study is to evaluate the ...
Status
Completed
Location
Antwerp University Hospital
Start Date
2014-08
Trial ID
NCT02227394
Treatments Being Tested
This is a randomised, active-comparator, open-label, parallel-group, multic...
Status
Completed
Location
Research Site
Start Date
2019-08-01
Trial ID
NCT03924635
Treatments Being Tested